Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Prescient Therapeutics.
RELATED STOCKHEAD STORIES
News
Last Orders: What you might have missed today on the ASX
Stockhead TV
ASX small caps leading the fight against cancer
Health & Biotech
Dr Boreham’s Crucible: Why Prescient now has ‘substance and sizzle’
Health & Biotech
Sophisticated and professional investors line up to give Prescient Therapeutics cash
Health & Biotech
Health Kick Podcast: Chemo’s diminishing role, the ‘personalised’ approach to cancer treatment and PTX’s CAR-T innovations
Health & Biotech
Prescient partners with global cancer heavyweight to develop new treatments
Health & Biotech
Prescient gears up for growth with $6.5m raise as the race to cure cancer heats up
Health & Biotech
Prescient, Antisense the only green shoots in a sea of red
News
ASX Small Cap Lunch Wrap: Who’s teaching an old dog new tricks today?
News
Rise and Shine: What you need to know before the ASX opens
News
Rise and Shine: What you need to know before the ASX opens
News
Rise and Shine: What you need to know before the ASX opens
News
Biotech: Bugkiller Bio-gene closes a $2.4m funding round as it eyes off new revenue streams
News
Lunchtime ASX Small Cap Wrap: Who’s afraid of the D-word today?
Health & Biotech
Cancer clinical trials continue as others are shut down on COVID-19 fears
Health & Biotech
Cancer Wars Part 1: These are the ASX small cap drugmakers that want to conquer cancer
Health & Biotech
